tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Terence Flynn, 134 are a HOLD (39.88%), 35 are a SELL (10.42%), 167 are a BUY (49.7%).
Analyst Terence Flynn, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 66.12% that have a potential upside of 20.86% achieved within 222 days.
Terence Flynn’s has documented 696 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RPRX, Royalty Pharma Plc at 16-May-2025.
Analyst best performing recommendations are on TBIO (TELESIS BIO).
The best stock recommendation documented was for ARVN (ARVINAS) at 11/13/2023. The price target of $20 was fulfilled within 2 days with a profit of $3.41 (20.55%) receiving and performance score of 102.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$38
$6.58 (20.94%)
$25
2 months 19 days ago
(04-Mar-2025)
2/3 (66.67%)
$3.89 (11.40%)
86
Buy
$32
$0.58 (1.85%)
$30
3 months 9 days ago
(14-Feb-2025)
13/18 (72.22%)
$-3.89 (-10.84%)
631
Hold
$46
$14.58 (46.40%)
$37
3 months 10 days ago
(13-Feb-2025)
19/23 (82.61%)
$10 (27.78%)
295
Buy
$40
$8.58 (27.31%)
$35
6 months 10 days ago
(13-Nov-2024)
4/6 (66.67%)
$10.76 (36.80%)
699
Buy
$36
$4.58 (14.58%)
$25
6 months 18 days ago
(05-Nov-2024)
20/27 (74.07%)
$7.63 (26.89%)
141
Which stock is Terence Flynn is most bullish on?
Which stock is Terence Flynn is most reserved on?
What Year was the first public recommendation made by Terence Flynn?
